Axsometherapeutics
Specialty Account Manager, Symbravo (Davenport, IA)
Davenport, IA. Posted 6 months ago
The role
The Specialty Account Manager will execute commercial activities for an assigned geography and promote SYMBRAVO. This person will manage territory performance, build customer relationships, and act as a disease category expert.
What you will do
- Assume full ownership of assigned territory performance
- Develop a comprehensive territory business plan
- Promote within approved labeling in a fair and ethical manner
- Develop strong customer relationships
- Serve as a resource regarding payer policies and processes
- Maximize use of marketing resources to grow customer confidence
- Communicate territory activity to management
- Provide feedback to sales, commercial leadership, and marketing
- Complete training classes and administrative duties
- Manage efforts within assigned promotional budget
Required qualifications
- Bachelor’s degree from an accredited college or university
- Minimum of 5 years of field customer experience and/or account management
- Minimum of 3 years Healthcare Professional experience with relevant CNS experience will also meet the qualifications
- 5 years of consistent top performance in the pharmaceutical, biotech or medical sales space
- Must live in the territory's geography
- Experience strategizing within cross-functional teams
- Ability to manage multiple tasks under aggressive timelines
- Strong digital marketing aptitude
- Strong interpersonal, presentation, and communication skills
- Frequent driving, including extended periods of time behind the wheel
- Prolonged sitting and standing
- Ability to lift and carry up to 30 lbs regularly and overhead reaching
Nice to have
- Migraine/CNS experience
- Launch experience
- Patient support services experience
Benefits
- Annual bonus
- Significant equity
- Generous benefits package
About the company
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous and psychiatric conditions. Their neuroscience portfolio includes FDA-approved treatments for major depressive disorder, narcolepsy, and migraine.